SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-169253
Filing Date
2022-06-07
Accepted
2022-06-07 16:01:55
Documents
14
Period of Report
2022-06-04
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d320692d8k.htm   iXBRL 8-K 31043
2 EX-99.1 d320692dex991.htm EX-99.1 32175
6 GRAPHIC g320692g0606233204080.jpg GRAPHIC 1984
  Complete submission text file 0001193125-22-169253.txt   201790

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vinc-20220604.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20220604_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20220604_pre.xml EX-101.PRE 11700
8 EXTRACTED XBRL INSTANCE DOCUMENT d320692d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 221001221
SIC: 2834 Pharmaceutical Preparations